Kindred Biosciences, Inc.
KIN
KIN was delisted on the 27th of August, 2021.
60 hedge funds and large institutions have $84.2M invested in Kindred Biosciences, Inc. in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 8 closing their positions.
5% less capital invested
Capital invested by funds: $88.7M → $84.2M (-$4.47M)
6% less funds holding
Funds holding: 64 → 60 (-4)
22% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 23
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$1.03M |
| 2 |
GTC
Ghost Tree Capital
New York
|
+$693K |
| 3 |
Renaissance Technologies
New York
|
+$650K |
| 4 |
CCI
Columbus Circle Investors
|
+$357K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$261K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$977K |
| 2 |
Morgan Stanley
New York
|
-$720K |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$667K |
| 4 |
DM
Deerfield Management
New York
|
-$504K |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$345K |
KIN Hedge Fund Activity: Q1 2015 in Review
60 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q1 2015, worth a combined $84.2M — down 5% from $88.7M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of KIN and 4 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 18 added.
The largest buyer was Ariel Investments, adding an estimated $1.03M. The largest seller was AWM Investment Company, exiting entirely with an estimated $977K sold.
- 60 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q1 2015, down from 64 in Q4 2014.
- Funds reported $84.2M of Kindred Biosciences, Inc. stock for Q1 2015, down 5% quarter-over-quarter.
- 4 funds opened new Kindred Biosciences, Inc. positions in Q1 2015 and 8 closed out, a net change of -4 holders.
- The largest Kindred Biosciences, Inc. buyer in Q1 2015 was Ariel Investments, an estimated $1.03M added.
- The largest Kindred Biosciences, Inc. seller in Q1 2015 was AWM Investment Company, an estimated $977K sold.
Based on aggregated 13F filings for Q1 2015.